X4 Pharmaceuticals (XFOR) EBT Growth (3y) (2020 - 2025)
X4 Pharmaceuticals (XFOR) EBT Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.48 Mn | -49.57 Mn | 2.20 Mn | 6.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.31% |
| Sep 30, 2025 | -11.38% |
| Jun 30, 2025 | -6.62% |
| Mar 31, 2025 | 26.29% |
| Dec 31, 2024 | -9.41% |
| Sep 30, 2024 | -22.06% |
| Jun 30, 2024 | 87.84% |
| Mar 31, 2024 | -40.47% |
| Dec 31, 2023 | -1.25% |
| Sep 30, 2023 | 49.26% |
| Jun 30, 2023 | -54.36% |
| Mar 31, 2023 | -29.77% |
| Dec 31, 2022 | -38.98% |
| Sep 30, 2022 | -6.83% |
| Jun 30, 2022 | -16.59% |
| Mar 31, 2022 | -26.37% |
| Dec 31, 2021 | -54.18% |
| Sep 30, 2021 | -32.65% |
| Jun 30, 2021 | -44.59% |
| Mar 31, 2021 | -44.09% |